Emapunil
Anxiety and other mood disorders
- CAS No.
- 226954-04-7
- Indication Class
- CNS / Psychiatry
- Patent Expiry
- Off-patent · 2020 (to verify)
- Therapeutic Area
- Psychiatry / Neurology
- Target / Mechanism
- TSPO
- Labeled Purity
- 98%+
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- Confirm per inquiry
- Patent Scope
- 2000s compound patent; expired per 20-yr term estimate — to be verified
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higherNo intermediate entries are on file for this API yet. You can still enquire by CAS number — we will route it to the supply side for manual sourcing.
Listing Logic · Why It's Worth Listing
Modulates neurosteroid synthesis via the TSPO pathway, avoiding benzodiazepine dependence, a non-sedating new direction in anxiolysis.
Psychiatry / Neurology · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
Intermediates confirmed per inquiry
Data File Pack
Product Description
Emapunil is an investigational ligand that selectively binds to the translocator protein (TSPO), a biomarker expressed on activated microglial cells in the central nervous system. It is under investigation for its potential in neurodegenerative disorders.
Supply source: Unibest · Emapunil, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.